focus -WSS

focus

author：Wikipedia 2025-10-02 01:07:31 - browse：1541

The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying coverage, and to speed up the pre-approval process in general.

The new rule applies to health insurance companies that offer Medicare, Medicaid, Children’s Health Insurance Program, and Obamacare plans. It concerns so-called prior authorization requests, and will require insurers to return urgent requests within 72 hours and non-urgent requests within seven days.

The changes are a win for patients seeking care, but also for health care providers like hospitals and physicians. Executives from California-based Sutter Health, Massachusetts General Brigham, and others repeatedly cited the rise in insurer denials since the pandemic at last week’s J.P. Morgan Healthcare conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： What's changing in Medicare's open enrollment this year?

focus

leisure time

WSS

How the drug

How the drug

PBMs are inflating the cost of generic drugs. They must be reined in

Kellogg’s is going to war over Mexico’s nutrition label rules

Cancer cells are shown to suck energy source from immune cells

How doctors and nurses shape Google's AI

Wikipedia

focus

focus

BioMarin wins approval for gene therapy to treat hemophilia A

A revolution in caring for preterm infants

Activists slam private health insurers over coverage restrictions

STAT Readout Newsletter: Today in biotech, life science news

BioMarin wins approval for gene therapy to treat hemophilia A

Health officials lay out plans to cope with respiratory virus season

Psychedelics group wrestles with new pharma identity

Can U.S. cancer drug shortages be fixed?

Activists slam private health insurers over coverage restrictions

Nick Jonas talks about managing diabetes along with his career

hotspot

Roche's accidental data boosts hopes for anti

FDA advisory panel to debate high blood pressure devices

What's changing in Medicare's open enrollment this year?

How should state employee insurance handle Wegovy?

Roche's accidental data boosts hopes for anti

There’s no way to know how good AI health technologies are

focus

leisure time

focus

explore